Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer’s Disease
暂无分享,去创建一个
S. Inoue | E. Masliah | S. Sugama | M. Waragai | M. Hashimoto | T. Takenouchi | H. Sugino | G. Ho
[1] E. Masliah,et al. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease , 2021, Biomolecules.
[2] H. Lashuel,et al. Reverse engineering Lewy bodies: how far have we come and how far can we go? , 2021, Nature Reviews Neuroscience.
[3] E. Masliah,et al. Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease , 2020, Journal of Alzheimer's disease : JAD.
[4] E. Masliah,et al. Adiponectin Paradox in Alzheimer's Disease; Relevance to Amyloidogenic Evolvability? , 2020, Frontiers in Endocrinology.
[5] A. Xu,et al. Higher Circulating Adiponectin Concentrations Predict Incident Cancer in Type 2 Diabetes - The Adiponectin Paradox. , 2020, The Journal of clinical endocrinology and metabolism.
[6] G. Knott,et al. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration , 2020, Proceedings of the National Academy of Sciences.
[7] Hiroshi I. Suzuki,et al. TGF-β Signaling in Cellular Senescence and Aging-Related Pathology , 2019, International journal of molecular sciences.
[8] E. Masliah,et al. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates , 2018, Journal of Parkinson's disease.
[9] E. Masliah,et al. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. , 2018, Drug discovery today.
[10] Liang‐Kung Chen,et al. The Association Between Serum Activin A Levels and Hypertension in the Elderly: A Cross-Sectional Analysis From I-Lan Longitudinal Aging Study , 2018, American journal of hypertension.
[11] E. Masliah,et al. Evolvability of Amyloidogenic Proteins in Human Brain , 2018, Journal of Alzheimer's disease : JAD.
[12] G. Paolisso,et al. Serum adiponectin levels are associated with worse cognitive function in postmenopausal women , 2017, PloS one.
[13] C. Antoniades,et al. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease , 2017, British journal of pharmacology.
[14] Frances Separovic,et al. Phosphorylation of a full length amyloid-β peptide modulates its amyloid aggregation, cell binding and neurotoxic properties. , 2017, Molecular bioSystems.
[15] A. van Maanen,et al. Circulating Activin A predicts survival in cancer patients , 2017, Journal of cachexia, sarcopenia and muscle.
[16] W. Greene,et al. Semen amyloids participate in spermatozoa selection and clearance , 2017, eLife.
[17] A. Murphy,et al. Activin A more prominently regulates muscle mass in primates than does GDF8 , 2017, Nature Communications.
[18] A. Yashin,et al. Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality , 2016, PLoS genetics.
[19] R. Wickner. Yeast and Fungal Prions. , 2016, Cold Spring Harbor perspectives in biology.
[20] C. Jack,et al. Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging. , 2016, Journal of Alzheimer's disease : JAD.
[21] R. Derynck,et al. TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology. , 2016, Cold Spring Harbor perspectives in biology.
[22] E. Masliah,et al. Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[23] D. D. de Kretser,et al. Activins in reproductive biology and beyond. , 2016, Human reproduction update.
[24] Ruitai Fan,et al. Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation. , 2015, Oncology letters.
[25] D. Franks,et al. The evolution of prolonged life after reproduction. , 2015, Trends in ecology & evolution.
[26] S. Brennecke,et al. Genome-Wide Transcriptome Directed Pathway Analysis of Maternal Pre-Eclampsia Susceptibility Genes , 2015, PloS one.
[27] Keith A. Johnson,et al. The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.
[28] G. Verleden,et al. Role of activin-A in cigarette smoke-induced inflammation and COPD , 2013, European Respiratory Journal.
[29] Sudha Seshadri,et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. , 2012, Archives of neurology.
[30] C. Hellerbrand,et al. Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. , 2011, Biochimica et biophysica acta.
[31] M. Marsden,et al. Integrin α5β1 Function Is Regulated by XGIPC/kermit2 Mediated Endocytosis during Xenopus laevis Gastrulation , 2010, PloS one.
[32] C. Saunders,et al. Comprehensive ZEB2 gene analysis for Mowat–Wilson syndrome in a North American cohort: A suggested approach to molecular diagnostics , 2009, American journal of medical genetics. Part A.
[33] C. Hill,et al. Tgf-beta superfamily signaling in embryonic development and homeostasis. , 2009, Developmental cell.
[34] J. Schölmerich,et al. Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes. , 2009, Cytokine.
[35] K. Tsuchida. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice. , 2008, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[36] M. Hedger,et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia , 2007, Proceedings of the National Academy of Sciences.
[37] C. Donaldson,et al. Pituitary actions of ligands of the TGF-β family: activins and inhibins , 2006 .
[38] T. Kirkwood,et al. Understanding the Odd Science of Aging , 2005, Cell.
[39] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[40] F. Petraglia,et al. Expression and secretion of activin A: possible physiological and clinical implications. , 2001, European journal of endocrinology.
[41] A. Baccarelli,et al. Activin A serum levels and aging of the pituitary-gonadal axis: a cross-sectional study in middle-aged and elderly healthy subjects , 2001, Experimental Gerontology.
[42] K. Lewis,et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling , 2000, Nature.
[43] S. Inoue,et al. Follistatin is a developmentally regulated cytokine in neural differentiation. , 1992, The Journal of biological chemistry.
[44] D. Robertson. Transforming growth factor /inhibin family , 1991 .
[45] W. Fischer,et al. Activin is a nerve cell survival molecule , 1990, Nature.
[46] H. Shibai,et al. Mesodermal induction in early amphibian embryos by activin A (erythroid differentiation factor) , 1990, Roux's archives of developmental biology.
[47] K. Titani,et al. Activin-binding protein from rat ovary is follistatin. , 1990, Science.
[48] N. Ling,et al. Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. , 1987, Molecular endocrinology.
[49] Joan Vaughan,et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid , 1986, Nature.
[50] Naoto Ueno,et al. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin , 1986, Nature.
[51] George C. Williams,et al. PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.
[52] K. Hruska,et al. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. , 2018, Kidney international.
[53] P. Papageorgis. Complex Interplay Between Aging and Cancer: Role of TGF-β Signaling. , 2017, Critical reviews in oncogenesis.
[54] N. Laping. Therapeutic uses of smad protein inhibitors: Selective inhibition of specific TGF-beta activities. , 1999, IDrugs : the investigational drugs journal.
[55] K. Tsuchida,et al. Activins and the receptor serine kinase superfamily. , 1995, Recent progress in hormone research.
[56] N. Ueno,et al. Activin as a cell differentiation factor. , 1990, Progress in growth factor research.
[57] E. Daume,et al. Purification of "inhibin" from human ovarian follicular fluid. , 1979, Acta endocrinologica.